Compounds > 5-s-cysteinyldopamine
Page last updated: 2024-09-03

5-s-cysteinyldopamine and Parkinson Disease, Secondary

5-s-cysteinyldopamine has been researched along with Parkinson Disease, Secondary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlsson, A; Fornstedt, B1

Reviews

1 review(s) available for 5-s-cysteinyldopamine and Parkinson Disease, Secondary

ArticleYear
Possible mechanisms underlying the special vulnerability of dopaminergic neurons.
    Acta neurologica Scandinavica. Supplementum, 1991, Volume: 136

    Topics: Aged; Aged, 80 and over; Animals; Brain; Cell Survival; Dopamine; Humans; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine

1991